[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
December 10, 2003

Recent Advances and Future Frontiers in Treating Age-Related Cataracts—Correction

JAMA. 2003;290(22):2943. doi:10.1001/jama.290.22.2943-a

Omitted Financial Disclosure: In the Contempo Updates article entitled "Recent Advances and Future Frontiers in Treating Age-Related Cataracts" published in the July 9, 2003, issue of THE JOURNAL (2003;290:248-251), a financial disclosure was not reported. The following should have been included: "Financial Disclosure: Dr Donnenfeld receives research support from Alcon, which manufactures moxifloxacin and ciprofloxacin for ophthalmic use. He also receives research support and is a consultant for Allergan, which manufactures gatifloxacin and ofloxacin for ophthalmic use."

×